| Bioactivity | Idraparinux (sodium) is a polymethylated synthetic pentasaccharide known to interact with the antithrombin III and act as anticoagulant. |
| Name | Idraparinux sodium |
| CAS | 149920-56-9 |
| Formula | C38H55Na9O49S7 |
| Molar Mass | 1727.18 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dey S, Lo HJ, Wong CH. An Efficient Modular One-Pot Synthesis of Heparin-Based Anticoagulant Idraparinux. J Am Chem Soc. 2019;141(26):10309-10314. [2]. Prandoni P, Tormene D, Perlati M, Brandolin B, Spiezia L. Idraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders. Expert Opin Investig Drugs. 2008;17(5):773-777. |
Idraparinux sodium
CAS: 149920-56-9 F: C38H55Na9O49S7 W: 1727.18
Idraparinux (sodium) is a polymethylated synthetic pentasaccharide known to interact with the antithrombin III and act a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.